Keros Therapeutics, Inc.

KROS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$559,931$331,147$279,048$230,042
Short-Term Investments$0$0$0$0
Receivables$4,456$1,091$841$18,197
Inventory$0$0$0$0
Other Curr. Assets$24,506$15,055$5,878$3,201
Total Curr. Assets$588,893$347,293$285,767$251,440
Property Plant & Equip (Net)$23,488$19,468$17,569$2,402
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,449$1,212$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,056$2,052$3,445$1,409
Total NC Assets$26,993$22,732$21,014$3,811
Other Assets$0$0$0$0
Total Assets$615,886$370,025$306,781$255,251
Liabilities
Payables$4,602$5,450$3,339$3,645
Short-Term Debt$1,978$1,005$455$862
Tax Payable$0$0$50$110
Deferred Revenue$0$0$0$0
Other Curr. Liab.$20,870$17,918$12,703$7,229
Total Curr. Liab.$27,450$24,373$16,547$11,846
LT Debt$16,883$13,439$12,811$231
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$16,883$13,439$12,811$231
Other Liabilities$0$0$0$0
Cap. Leases$18,861$14,444$13,266$1,093
Total Liabilities$44,333$37,812$29,358$12,077
Equity
Pref Stock$0$0$0$0
Common Stock$4$3$2$2
Retained Earnings-$568,779-$381,426-$228,434-$123,755
AOCI$0$0$0$0
Other Equity$1,140,328$713,636$505,855$366,927
Total Equity$571,553$332,213$277,423$243,174
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$615,886$370,025$306,781$255,251
Net Debt-$541,070-$316,703-$265,782-$228,949